Overview
Spherix’s coverage of emerging neurology indications focuses on evolving markets where a paradigm shift is expected in the coming years.
Services Available
Prepping for the pipeline
Amyotrophic Lateral Sclerosis (US)
Benchmarking new brand performance
Aducanumab (Biogen) in Alzheimer’s Disease (US)*
*Pending approvals and launch